ada standards of care 2025 obesity pharmacotherapy glp-1 in Overweight and 2026 Guidelines Update – Key Changes for Pharmacologic Treatment Outlook for obesity in 2025:

The Importance of Personalization This is where the value of a tailored approach becomes evident

Lyophilized, 99%+ HPLC-verified

Perimenopause builds over months and years whether your life is calm or on fire

PSM Executive Director Shabbir Imber Safdar released the following statement in response to news that Hims & Hers is now compounding pill versions of a newly approved GLP-1 weight-loss drug

Clinical Studies Supporting Semaglutide Medical Weight Loss in Sevierville, TN As one of the few healthcare clinics available in rural areas and along trucking routes, we often get questions from members of the community about our medical weight loss plans